The expression of MAfG (MAF bZIP transcription factor G) increases in cells and tissues with cholestasis, as well as in human cholangiocarcinoma and HCC in which MAFG overexpression correlates with tumor progression and reduced survival time [163,164]. This evidence concerns the gene MAFG and cholangiocarcinoma.